With key components being built on EigenCloud, Myriad Protocol is designed to power prediction markets "everywhere, for ...

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in ...

This week’s top prediction markets on Myriad cover Bitcoin' recent price surge, PENGU's ETF approval chances, Wimbledon, and ...

Demolition continues Wednesday, July 2, on the old Myriad Convention Center that is the site of the new arena. Check out our latest photos: ...

Myriad Genetics' RiskScore improves breast cancer screening recommendations based on individual risk assessments, as shown in a recent study. Quiver AI Summary ...

SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual ...

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 36% in the afternoon session after the company reported mixed first quarter 2025 results: it lowered its full-year revenue, EPS ...

Myriad Genetics' growth potential lies in its innovative products, strong financials, and expanding market opportunities. Learn why MYGN stock is a Buy.